Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost sales and jolt the stock. The company's long-term prospects look attractive ...

・Shares moved premarket as Wall Street highlighted that a potential Abbott deal would likely require a valuation well above prior estimates. ・William Blair said even conservative modeling supports a ...

Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...